1. Home
  2. PLAB vs BCYC Comparison

PLAB vs BCYC Comparison

Compare PLAB & BCYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Photronics Inc.

PLAB

Photronics Inc.

HOLD

Current Price

$34.36

Market Cap

2.0B

Sector

Technology

ML Signal

HOLD

Logo Bicycle Therapeutics plc

BCYC

Bicycle Therapeutics plc

HOLD

Current Price

$5.01

Market Cap

360.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLAB
BCYC
Founded
1969
2009
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
360.7M
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
PLAB
BCYC
Price
$34.36
$5.01
Analyst Decision
Strong Buy
Buy
Analyst Count
2
9
Target Price
$43.50
$17.56
AVG Volume (30 Days)
992.7K
341.4K
Earning Date
05-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
9.09
42.91
EPS
0.74
N/A
Revenue
$535,276,000.00
N/A
Revenue This Year
$6.48
N/A
Revenue Next Year
$6.75
N/A
P/E Ratio
$45.33
N/A
Revenue Growth
18.77
N/A
52 Week Low
$16.46
$4.77
52 Week High
$45.40
$9.94

Technical Indicators

Market Signals
Indicator
PLAB
BCYC
Relative Strength Index (RSI) 46.65 38.55
Support Level $31.98 N/A
Resistance Level $38.00 $5.90
Average True Range (ATR) 2.33 0.27
MACD -0.47 -0.02
Stochastic Oscillator 15.63 23.11

Price Performance

Historical Comparison
PLAB
BCYC

About PLAB Photronics Inc.

Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

Share on Social Networks: